NASDAQ:XLO | Key Financial Ratios | Xilio Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-304.25-14.15%-30.21%
2026-03-313.59-19.15%-43.15%
2025-12-312.58-22.65%-99.33%
2025-09-302.2-43.75%722.53%
2025-06-302.32-42.02%-795.33%
2025-03-311.96-52.36%-507.50%
2024-12-312.21-81.94%-330.95%
2024-09-301.67-84.12%-299.43%
2024-06-302.02-72.92%-196.11%
2024-03-312.19-85.90%-275.42%
2023-12-313.02-125.40%-207.47%
2023-09-303.81-104.33%-154.70%
2023-06-304.81-91.23%-125.05%
2023-03-315.99-80.28%-105.57%
2022-12-315.89-63.39%-83.51%
2022-09-308.45-54.29%-67.66%
2022-06-309.17-45.99%-56.80%
2022-03-3114.81-40.99%-48.45%
2021-12-3115.85-34.76%-40.88%
2021-09-308.2-63.67%56.33%
2021-06-3062.19%
2021-03-3164.32%
2020-12-310.93-152.05%66.30%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-312.58-22.65%-99.33%
2024-12-312.21-81.94%-330.95%
2023-12-313.02-125.40%-207.47%
2022-12-315.89-63.39%-83.51%
2021-12-3115.85-34.76%-40.88%
2020-12-310.93-152.05%66.30%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.